Chemical Structure : Toripalimab
CAS No.: 1924598-82-2
货号: PC-Ab1103Not For Human Use, Lab Use Only.
Toripalimab (JS 001, SO-001, TAB-001) is an anti-PD-1 monoclonal antibody developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, and for enhanced receptor endocytosis function. Blocking PD-1 interactions with PD-L1 and PD-L2 is thought to recharge the immune system’s ability to attack and kill tumor cells..
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥3580 | In stock | |
5 mg | ¥7580 | In stock | |
10 mg | ¥12800 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Toripalimab (JS 001, SO-001, TAB-001) is an anti-PD-1 monoclonal antibody developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, and for enhanced receptor endocytosis function. Blocking PD-1 interactions with PD-L1 and PD-L2 is thought to recharge the immune system’s ability to attack and kill tumor cells.
分子量 | ||
分子式 | Human IgG4P-Kappa | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
PBS, pH 7.0 Contains no stabilizers or preservatives |
|
Chemical Name/SMILES |
Toripalimab; JS 001; SO-001; TAB-001; Terepril monoclonal antibody; Treipril monoclonal antibody; Treprizumab; Treprizumab; 1924598-82-2; Tripleitriumab; Triprizumab; Anti-human programmed death receptor-1; Anti-human PD1 |
1. 1, Tang B, et al. J Hematol Oncol. 2019 Jan 14;12(1):7. 2, Liu H, et al. MAbs. 2019 May/Jun;11(4):681-690. 3, Sheng X, et al. J Clin Oncol. 2019 Nov 10;37(32):2987-2999.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright